https://clinicaltrials.gov/ct2/show/NCT03259074?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=09%2F24%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)
DESCRIPTION:
Condition: Ankylosing Spondylitis
Interventions: Biological: Secukinumab; Biological: GP2017 (adalimumab biosimilar)
Sponsor: Novartis Pharmaceuticals
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03259074
FIRST POSTED:
Wed, 23 Aug 2017 12:00:00 EDT
LAST UPDATE POSTED:
10/08/19 08:16AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03259074?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=09%2F24%2F2019&lupd_d=14&sort=nwst
